1.
J Psychiatry Neurosci
; 30(6): 430-1, 2005 Nov.
Article
in English
| MEDLINE
| ID: mdl-16327877
ABSTRACT
We describe the cases of 2 men with chronic combat-induced post-traumatic stress disorder (PTSD) who benefited from therapy with ziprasidone. They did not have active psychotic symptoms. Both the patients had a history of inadequate response to previous trials of different psychotropic agents. Ziprasidone was considered because of its broad-spectrum actions on various neurotransmitters. To our knowledge, this is the first published report of the usefulness of ziprasidone in the pharmacotherapy of PTSD, although atypical antipsychotic agents (e.g., olanzapine, quetiapine and risperidone) have been reported to be beneficial in the treatment of this condition.
Subject(s)
Antipsychotic Agents/therapeutic use , Piperazines/therapeutic use , Stress Disorders, Post-Traumatic/drug therapy , Thiazoles/therapeutic use , Combat Disorders/drug therapy , Combat Disorders/psychology , Humans , Male , Middle Aged , Stress Disorders, Post-Traumatic/psychology
2.
Ann Pharmacother
; 39(9): 1578-9, 2005 Sep.
Article
in English
| MEDLINE
| ID: mdl-16046488
3.
Am J Psychiatry
; 159(12): 2114, 2002 Dec.
Article
in English
| MEDLINE
| ID: mdl-12450973